Patents by Inventor Samirkumar Patel

Samirkumar Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180042765
    Abstract: The present invention relates to a methods and devices for treating uveitis, macular edema associated with uveitis and macular edema associated with retinal vein occlusion in a human subject in need thereof. In certain aspects, devices provided herein include a medicament container defining a lumen configured to contain a medicament, a distal end portion of the medicament container including a coupling portion configured to be removably coupled to a needle assembly, a proximal end portion of the medicament container including a flange and a longitudinal shoulder; a piston assembly including a distal end portion movably disposed within the lumen of the medicament container; and a handle coupled to a proximal end portion of the piston assembly.
    Type: Application
    Filed: June 17, 2015
    Publication date: February 15, 2018
    Inventors: Glenn NORONHA, Christopher John BROOKS, Rafael Victor ANDINO, Samirkumar PATEL, Daniel WHITE
  • Publication number: 20180028516
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Application
    Filed: March 9, 2017
    Publication date: February 1, 2018
    Inventors: Vladimir ZARNITSYN, Samirkumar PATEL, Daniel WHITE, Glenn NORONHA, Brian BURKE
  • Publication number: 20170333416
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Application
    Filed: August 9, 2017
    Publication date: November 23, 2017
    Inventors: Vladimir ZARNITSYN, Samirkumar PATEL, Daniel WHITE, Glenn NORONHA, Brian BURKE
  • Publication number: 20170169429
    Abstract: A user device may request an account type identifier that identifies an account type associated with the user device. The user device may receive the account type identifier based on requesting the account type identifier. The user device may compare the account type identifier and a set of account type identifiers corresponding to a set of user device configurations to be enabled or disabled by the user device based on the account type identifier. The user device may enable a first subset of user device configurations, included in the set of user device configurations that are associated with the account type identifier. The user device may disable a second subset of user device configurations, included in the set of user device configurations that are not associated with the account type identifier.
    Type: Application
    Filed: December 14, 2015
    Publication date: June 15, 2017
    Inventors: Zhengfang CHEN, Masudur RAHMAN, Farook KALEEM, Samirkumar PATEL
  • Patent number: 9636332
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Grant
    Filed: January 20, 2016
    Date of Patent: May 2, 2017
    Assignee: CLEARSIDE BIOMEDICAL, INC.
    Inventors: Vladimir Zarnitsyn, Samirkumar Patel, Daniel White, Glenn Noronha, Brian Burke
  • Patent number: 9572800
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: February 21, 2017
    Assignee: CLEARSIDE BIOMEDICAL, INC.
    Inventors: Vladimir Zarnitsyn, Samirkumar Patel, Daniel White, Glenn Noronha, Brian Burke, Jennifer Kissner
  • Publication number: 20160213662
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Application
    Filed: March 31, 2016
    Publication date: July 28, 2016
    Inventors: Vladimir ZARNITSYN, Samirkumar PATEL, Daniel WHITE, Glenn NORONHA, Brian BURKE
  • Publication number: 20160206628
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Application
    Filed: January 20, 2016
    Publication date: July 21, 2016
    Applicant: Clearside Biomedical, Inc.
    Inventors: Vladimir ZARNITSYN, Samirkumar PATEL, Daniel WHITE, Glenn NORONHA, Brian BURKE
  • Publication number: 20150258120
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Application
    Filed: November 8, 2013
    Publication date: September 17, 2015
    Inventors: Vladimir Zarnitsyn, Samirkumar Patel, Daniel White, Glenn Noronha, Brian Burke